The effort to make a breakthrough cancer therapy cheaper
CAR-T cells could revolutionize the treatment of a wide variety of diseases, if only we can make them cheaper.
Source: technologyreview.com
📰 Caring Cross News
Caring Cross News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Caring Cross. Real-time updates on events, politics, business and more.
Readout Newsletter: Blackstone Life Sciences, Merck, Bluebird Bio
Today's biotech news includes a potentially major drug approval, an idea to make CAR-T more equitable, and the slow launch of a gene therapy.
United States Estado Do Rio Adam Feuerstein Amylyx Pharma Blackstone Life Sciences Foundation Medicine
Source: statnews.com
Brazil and Caring Cross to Produce Affordable CAR-T, Stem Cell Gene Therapies
Brazil’s Ministry of Health and nonprofit Caring Cross announced a collaboration Tuesday aimed at local manufacturing of CAR-T cell and stem cell gene therapies at a much lower cost than Europe and the U.S.
Source: biospace.com
UC Davis exceeds $1 billion in research awards for second year
UC Davis exceeded $1 billion in new external research awards in the fiscal year 2022-23 following the record set the previous year.
Source: dailydemocrat.com
Maryland Stem Cell Research Commission Announces Over $14 Million in Awards to Accelerate Cures
/PRNewswire/ -- The Maryland Stem Cell Research (MSCRF) Commission is pleased to announce over $14.1 million in grant awards to promote innovative research...
United States College Park Baltimore County Johns Hopkins University University Of Maryland Warren Grayson
Source: prnewswire.com
Vector BioMed Appoints Jakob Reiser, Ph.D., as Senior Director of Regulatory Affairs
/PRNewswire/ -- Vector BioMed, a biomanufacturing company specializing in the manufacture of lentiviral vectors, today announced the appointment of Jakob...
Source: prnewswire.com
Biomanufacturing Company Vector BioMed Launches with Mission to Provide Access to High-Quality Lentiviral Vectors and Address the Vector Supply Bottleneck
/PRNewswire/ -- Vector BioMed, a biomanufacturing company specializing in the manufacture of lentiviral vectors, today announced its launch and first financing...
Source: prnewswire.com
CDMO Startup Vector BioMed Launches to Fill Lentiviral Gap for Cell & Gene Therapies
Vector BioMed has developed a technology platform for designing and manufacturing the lentiviruses used to deliver cell and gene therapies. The startup is launching as the field continues to experience shortages of these viral vectors.
Source: medcitynews.com
Researchers Explore CAR-T Therapy as a Potential Cure for HIV
A “living drug” could potentially eliminate HIV-infected cells, allowing for long-term remission without antiretroviral therapy.
United States University Of California San Francisco San Francisco University Of California Davis Rimas Orentas Steven Deeks
Source: poz.com
Caring Cross Presents Research Involving Anti-HIV DuoCAR-T Cell Therapy at the Conference on Retroviruses and Opportunistic Infections (CROI) 2022
/PRNewswire/ -- Caring Cross, a 501(c)(3) non-profit dedicated to accelerating the development of advanced medicines and enabling access to cures for all...
Source: prnewswire.com